Results 91 to 100 of about 2,895 (208)

Transformative Impact of Nanocarrier‐Mediated Drug Delivery: Overcoming Biological Barriers and Expanding Therapeutic Horizons

open access: yesSmall Science, Volume 4, Issue 11, November 2024.
The development of drug delivery systems is revolutionizing therapeutic progress by ensuring precise targeting and optimal drug concentrations. Nanocarriers, with their customizable properties and controlled release, overcome biological barriers to improve treatment outcomes. This study explores the potential of integrating artificial intelligence with
Minhye Kim   +4 more
wiley   +1 more source

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis [PDF]

open access: yes, 2019
Background: Etelcalcetide is an intravenous calcimimetic approved for treatment of secondary hyperparathyroidism (sHPT) in patients receiving hemodialysis. Besides lowering parathyroid hormone (PTH), etelcalcetide also significantly reduces fibroblast
Block, Geoffrey A.   +9 more
core   +1 more source

Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis [PDF]

open access: yesJournal of Nephropathology
Introduction: Hyperphosphatemia is an independent risk factor for mortality in chronic kidney disease (CKD) patients. Objectives: This systematic review and meta-analysis aimed to investigate the effect of Sevelamer on serum phosphorus levels in CKD and ...
Farshad Gharebakhshi   +8 more
doaj   +1 more source

Calcinosis cutis of the lower legs – hyperphosphatemic familial tumoral calcinosis in a patient with GALNT3 mutation

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 9, Page 1144-1146, September 2025.
David Ranzinger   +4 more
wiley   +1 more source

Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE−/−) mice with chronic renal failure [PDF]

open access: yes, 2017
Background. In chronic kidney disease (CKD) patients, the intake of calcium-based phosphate binders is associated with a marked progression of coronary artery and aortic calcification, in contrast to patients receiving calcium-free phosphate binders. The
Chasseraud, Maud   +10 more
core  

The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report

open access: yes
Journal of Paediatrics and Child Health, Volume 61, Issue 8, Page 1332-1337, August 2025.
Farrah Rodrigues   +3 more
wiley   +1 more source

The connections between vascular calcification and bone health [PDF]

open access: yes, 2013
Vascular calcification, bone loss and increased fracture risk are age-associated disorders. Several epidemiological studies have suggested a relationship between vascular calcification, impaired bone metabolism and increased mortality.
Cannata, J.B. (Jorge)   +2 more
core  

The Case | Ectopic calcifications in a child [PDF]

open access: yes, 2015
The case A nine year old boy, born of third degree consanguinity, presented with a hard left scapular swelling for 6 months. There was no history of fever, trauma or weight loss. There was no pain, redness or discharge. This mass was excised but recurred
Econs, Michael J.   +6 more
core   +2 more sources

Fibroblast Growth Factor-23 (FGF-23) e Sindrome Cardiorenale

open access: yesGiornale di Clinica Nefrologia e Dialisi, 2015
non disponibile (Cardionephrology)
Luca Di Lullo   +6 more
doaj   +1 more source

Interleukin-18 enhances vascular calcification and osteogenic differentiation of vascular smooth muscle cells through TRPM7 channel activation [PDF]

open access: yes, 2017
Objective—Vascular calcification (VC) is an important predictor of cardiovascular morbidity and mortality. Osteogenic differentiation of vascular smooth muscle cells (VSMCs) is a key mechanism of VC. Recent studies show that IL-18 (interleukin-18) favors
Chen, Jie   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy